Catalyst Wire Dossier Catalyst Wire Dossier

11C-ORM-13070

· Orion Corporation, Orion Pharma
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 11C-ORM-13070, covering 2009-11-25 to 2013-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline [Phase 1]

See pricing